Pages that link to "Q45986283"

The following pages link to Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders. (Q45986283):

Displaying 26 items.

• Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function (Q24629901) (← links)
• Targeting the molecular and cellular interactions of the bone marrow niche in immunologic disease (Q26865498) (← links)
• Sphingosine kinase localization in the control of sphingolipid metabolism (Q34810283) (← links)
• S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart (Q34979795) (← links)
• High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes (Q35755147) (← links)
• Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues (Q36145233) (← links)
• Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila (Q36444141) (← links)
• Increased sphingosine-1-phosphate improves muscle regeneration in acutely injured mdx mice (Q37114072) (← links)
• Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy (Q37438488) (← links)
• The discovery of novel experimental therapies for inflammatory arthritis (Q37719255) (← links)
• Fingolimod is a potential novel therapy for multiple sclerosis (Q37765473) (← links)
• 1-Amino-1-deoxy-D-fructose ("fructosamine") and its derivatives. (Q37788385) (← links)
• PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism (Q37895205) (← links)
• Immunological function of sphingosine 1-phosphate in the intestine (Q38016160) (← links)
• Sphingosine-1-phosphate metabolism: A structural perspective (Q38448843) (← links)
• Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism (Q38915115) (← links)
• Fluorescent THF-based fructose analogue exhibits fructose-dependent uptake (Q39137460) (← links)
• Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis (Q39356027) (← links)
• Implication of sphingosine-1-phosphate signaling in diseases: molecular mechanism and therapeutic strategies (Q40113378) (← links)
• A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome (Q40991982) (← links)
• Enantioselective N-heterocyclic carbene catalyzed annulation reactions with imidazolidinones (Q41898589) (← links)
• The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner (Q42062961) (← links)
• Sphingosine kinase 1-associated autophagy differs between neurons and astrocytes. (Q54111173) (← links)
• Inhibition of human pyridoxal kinase by 2-acetyl-4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)imidazole (THI). (Q54347181) (← links)
• Sphingosine-1-phosphate lyase is expressed by CD68+cells on the parenchymal side of marginal reticular cells in human lymph nodes (Q63312844) (← links)
• Sphingosine 1-phosphate lyase inhibition by 2-acetyl-4-(tetrahydroxybutyl)imidazole (THI) under conditions of vitamin B6 deficiency (Q85932155) (← links)